Author: K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Provisional Performance (Consolidated Financial Results) / 2024-01-24
[Disclosure] Samsung Biologics (207940) – Change in Profit and Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-01-24